Nascent Biotech, Inc.
NBIO
$0.0007
-$0.0001-12.50%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.40K | 372.10K | 623.90K | 1.00M | 9.50K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 180.00K | 180.00K | 17.40K | 38.70K | 69.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 227.40K | 552.10K | 641.30K | 1.04M | 78.90K |
|
|
|||||
| Total Current Assets | 227.40K | 552.10K | 641.30K | 1.04M | 78.90K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 227.40K | 552.10K | 641.30K | 1.04M | 78.90K |
|
|
|||||
| Total Accounts Payable | 682.90K | 686.30K | 483.80K | 510.10K | 644.30K |
| Total Accrued Expenses | -- | -- | 2.20K | 54.00K | -- |
| Short-term Debt | 59.00K | 122.50K | 125.00K | 305.00K | 277.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 180.00K | 312.70K |
| Total Other Current Liabilities | -- | -- | -- | 180.00K | 312.70K |
| Total Current Liabilities | 741.90K | 808.80K | 610.90K | 1.05M | 1.23M |
|
|
|||||
| Total Current Liabilities | 741.90K | 808.80K | 610.90K | 1.05M | 1.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 59.00K | 122.50K | 125.00K | 305.00K | 277.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | -- |
| Total Liabilities | 741.90K | 808.80K | 610.90K | 1.05M | 1.23M |
|
|
|||||
| Common Stock & APIC | 24.12M | 24.00M | 23.78M | 23.54M | 21.01M |
| Retained Earnings | -24.64M | -24.26M | -23.75M | -23.54M | -22.16M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -514.50K | -256.70K | 30.40K | -6.40K | -1.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -514.50K | -256.70K | 30.40K | -6.40K | -1.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -514.50K | -256.70K | 30.40K | -6.40K | -1.16M |
|
|
|||||